相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Induction chemotherapy followed by intensity-modulated radiotherapy versus concurrent chemoradiotherapy in nasopharyngeal carcinoma: A retrospective analysis
Yan He et al.
CLINICAL OTOLARYNGOLOGY (2021)
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma
Ling-Long Tang et al.
CANCER COMMUNICATIONS (2021)
Circulating Epstein-Barr virus DNA level post induction chemotherapy contributes to prognostication in advanced-stage nasopharyngeal carcinoma
Fo-Ping Chen et al.
EUROPEAN JOURNAL OF CANCER (2021)
A systematic review and recommendations on the use of plasma EBV DNA for nasopharyngeal carcinoma
Anne W. M. Lee et al.
EUROPEAN JOURNAL OF CANCER (2021)
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
Yu-Pei Chen et al.
LANCET (2021)
Prognostic Value of Plasma Epstein-Barr Virus DNA Levels Pre- and Post-Neoadjuvant Chemotherapy in Patients With Nasopharyngeal Carcinoma
Lisheng Zhu et al.
FRONTIERS IN ONCOLOGY (2021)
y Influence of concurrent chemotherapy on locoregionally advanced nasopharyngeal carcinoma treated with neoadjuvant chemotherapy plus intensity-modulated radiotherapy: A retrospective matched analysis
Fangzheng Wang et al.
SCIENTIFIC REPORTS (2020)
Nomogram Predicting the Benefits of Adding Concurrent Chemotherapy to Intensity-Modulated Radiotherapy After Induction Chemotherapy in Stages II-IVb Nasopharyngeal Carcinoma
Sai-Lan Liu et al.
FRONTIERS IN ONCOLOGY (2020)
Induction chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinoma
Li-Ting Liu et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Plasma Epstein-Barr Virus DNA Load After Induction Chemotherapy Predicts Outcome in Locoregionally Advanced Nasopharyngeal Carcinoma
Cheng-Long Huang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
Yuan Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Liquid biopsy tracking during sequential chemo-radiotherapy identifies distinct prognostic phenotypes in nasopharyngeal carcinoma
Jiawei Lv et al.
NATURE COMMUNICATIONS (2019)
Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial
Wen-Fei Li et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
Ying Sun et al.
LANCET ONCOLOGY (2016)
The Prognostic Value of Plasma Epstein-Barr Viral DNA and Tumor Response to Neoadjuvant Chemotherapy in Advanced-Stage Nasopharyngeal Carcinoma
Li-Ting Liu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective
Anne W. M. Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost
Xiaomin Ou et al.
ONCOTARGET (2015)
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial
Lei Chen et al.
LANCET ONCOLOGY (2012)
Increased treatment-related mortality with additional cisplatin-based chemotherapy in patients with nasopharyngeal carcinoma treated with standard radiotherapy
An-Mei Zhang et al.
RADIOTHERAPY AND ONCOLOGY (2012)
Concurrent Chemoradiotherapy vs Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: Phase III Randomized Trial
Qiu-Yan Chen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Randomized Trial of Radiotherapy Plus Concurrent-Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma
Anne W. M. Lee et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group
AWM Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer stage III and IV nasopharyngeal cancer of the endemic variety
J Wee et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
分享论文
